KSD-101 Therapy for EBV-associated Lymphomas: an Exploratory Clinical Trial

Clinical trial NCT05882305 · WITHDRAWN

Trial details

NCT number: NCT05882305
Sponsor: Kousai Bio Co., Ltd.
Status: WITHDRAWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

EBV-associated Lymphomas

Start date: 2023-06-10
Primary completion: 2024-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.